Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Genet ; 17(4): e1009112, 2021 04.
Article in English | MEDLINE | ID: mdl-33819264

ABSTRACT

We previously identified a deletion on chromosome 16p12.1 that is mostly inherited and associated with multiple neurodevelopmental outcomes, where severely affected probands carried an excess of rare pathogenic variants compared to mildly affected carrier parents. We hypothesized that the 16p12.1 deletion sensitizes the genome for disease, while "second-hits" in the genetic background modulate the phenotypic trajectory. To test this model, we examined how neurodevelopmental defects conferred by knockdown of individual 16p12.1 homologs are modulated by simultaneous knockdown of homologs of "second-hit" genes in Drosophila melanogaster and Xenopus laevis. We observed that knockdown of 16p12.1 homologs affect multiple phenotypic domains, leading to delayed developmental timing, seizure susceptibility, brain alterations, abnormal dendrite and axonal morphology, and cellular proliferation defects. Compared to genes within the 16p11.2 deletion, which has higher de novo occurrence, 16p12.1 homologs were less likely to interact with each other in Drosophila models or a human brain-specific interaction network, suggesting that interactions with "second-hit" genes may confer higher impact towards neurodevelopmental phenotypes. Assessment of 212 pairwise interactions in Drosophila between 16p12.1 homologs and 76 homologs of patient-specific "second-hit" genes (such as ARID1B and CACNA1A), genes within neurodevelopmental pathways (such as PTEN and UBE3A), and transcriptomic targets (such as DSCAM and TRRAP) identified genetic interactions in 63% of the tested pairs. In 11 out of 15 families, patient-specific "second-hits" enhanced or suppressed the phenotypic effects of one or many 16p12.1 homologs in 32/96 pairwise combinations tested. In fact, homologs of SETD5 synergistically interacted with homologs of MOSMO in both Drosophila and X. laevis, leading to modified cellular and brain phenotypes, as well as axon outgrowth defects that were not observed with knockdown of either individual homolog. Our results suggest that several 16p12.1 genes sensitize the genome towards neurodevelopmental defects, and complex interactions with "second-hit" genes determine the ultimate phenotypic manifestation.


Subject(s)
Brain/metabolism , Chromosome Deletion , Chromosomes, Human, Pair 16/genetics , Neurodevelopmental Disorders/genetics , Adaptor Proteins, Signal Transducing/genetics , Animals , Brain/pathology , Calcium Channels/genetics , Cell Adhesion Molecules/genetics , DNA-Binding Proteins/genetics , Disease Models, Animal , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Epistasis, Genetic/genetics , Gene Expression Regulation, Developmental , Humans , Methyltransferases/genetics , Neurodevelopmental Disorders/pathology , Nuclear Proteins/genetics , PTEN Phosphohydrolase/genetics , Transcription Factors/genetics , Ubiquitin-Protein Ligases/genetics , Xenopus Proteins/genetics , Xenopus laevis/genetics
2.
PLoS Genet ; 16(2): e1008590, 2020 02.
Article in English | MEDLINE | ID: mdl-32053595

ABSTRACT

The 1.6 Mbp deletion on chromosome 3q29 is associated with a range of neurodevelopmental disorders, including schizophrenia, autism, microcephaly, and intellectual disability. Despite its importance towards neurodevelopment, the role of individual genes, genetic interactions, and disrupted biological mechanisms underlying the deletion have not been thoroughly characterized. Here, we used quantitative methods to assay Drosophila melanogaster and Xenopus laevis models with tissue-specific individual and pairwise knockdown of 14 homologs of genes within the 3q29 region. We identified developmental, cellular, and neuronal phenotypes for multiple homologs of 3q29 genes, potentially due to altered apoptosis and cell cycle mechanisms during development. Using the fly eye, we screened for 314 pairwise knockdowns of homologs of 3q29 genes and identified 44 interactions between pairs of homologs and 34 interactions with other neurodevelopmental genes. Interestingly, NCBP2 homologs in Drosophila (Cbp20) and X. laevis (ncbp2) enhanced the phenotypes of homologs of the other 3q29 genes, leading to significant increases in apoptosis that disrupted cellular organization and brain morphology. These cellular and neuronal defects were rescued with overexpression of the apoptosis inhibitors Diap1 and xiap in both models, suggesting that apoptosis is one of several potential biological mechanisms disrupted by the deletion. NCBP2 was also highly connected to other 3q29 genes in a human brain-specific interaction network, providing support for the relevance of our results towards the human deletion. Overall, our study suggests that NCBP2-mediated genetic interactions within the 3q29 region disrupt apoptosis and cell cycle mechanisms during development.


Subject(s)
Brain/embryology , Chromosomes, Human, Pair 3/genetics , Drosophila Proteins/genetics , Embryonic Development/genetics , Intellectual Disability/genetics , Nuclear Cap-Binding Protein Complex/genetics , Xenopus Proteins/genetics , Animals , Apoptosis/genetics , Brain/pathology , Cell Cycle/genetics , Chromosome Deletion , Developmental Disabilities/genetics , Developmental Disabilities/pathology , Disease Models, Animal , Drosophila Proteins/metabolism , Drosophila melanogaster , Embryo, Nonmammalian , Female , Gene Expression Regulation, Developmental , Gene Knockdown Techniques , Gene Regulatory Networks , Humans , Intellectual Disability/pathology , Nuclear Cap-Binding Protein Complex/metabolism , Xenopus Proteins/metabolism , Xenopus laevis
SELECTION OF CITATIONS
SEARCH DETAIL
...